Bayesian Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $405K | Buy |
+7,779
| New | +$405K | 0.06% | 330 |
|
|
2024
Q2 | – | Sell |
-6,104
| Closed | -$489K | – | 797 |
|
|
2024
Q1 | $489K | Buy |
+6,104
| New | +$489K | 0.05% | 442 |
|
|
2023
Q4 | – | Sell |
-6,021
| Closed | -$607K | – | 794 |
|
|
2023
Q3 | $607K | Buy |
+6,021
| New | +$607K | 0.07% | 332 |
|
|
2023
Q1 | – | Sell |
-5,349
| Closed | -$474K | – | 833 |
|
|
2022
Q4 | $474K | Sell |
5,349
-2,400
| -31% | -$213K | 0.07% | 371 |
|
|
2022
Q3 | $621K | Buy |
+7,749
| New | +$621K | 0.13% | 233 |
|
|
2020
Q4 | – | Sell |
-5,386
| Closed | -$424K | – | 482 |
|
|
2020
Q3 | $424K | Sell |
5,386
-3,496
| -39% | -$275K | 0.1% | 263 |
|
|
2020
Q2 | $639K | Buy |
8,882
+180
| +2% | +$13K | 0.14% | 204 |
|
|
2020
Q1 | $498K | Buy |
8,702
+5,200
| +148% | +$298K | 0.11% | 296 |
|
|
2019
Q4 | $392K | Buy |
+3,502
| New | +$392K | 0.07% | 360 |
|
|
2018
Q4 | – | Sell |
-3,699
| Closed | -$293K | – | 632 |
|
|
2018
Q3 | $293K | Sell |
3,699
-500
| -12% | -$39.6K | 0.05% | 466 |
|
|
2018
Q2 | $307K | Buy |
+4,199
| New | +$307K | 0.07% | 389 |
|
|
2017
Q1 | – | Sell |
-6,200
| Closed | -$274K | – | 446 |
|
|
2016
Q4 | $274K | Buy |
+6,200
| New | +$274K | 0.07% | 448 |
|
|
2016
Q2 | – | Sell |
-6,000
| Closed | -$252K | – | 415 |
|
|
2016
Q1 | $252K | Buy |
+6,000
| New | +$252K | 0.24% | 213 |
|